Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...
Plasma physicist Debbie Callahan, chief strategy officer at Focused Energy, talks to Hamish Johnston about her work in laser fusion research ...
Procode Inc., an AI-powered revenue cycle management (RCM) company, launches with $4 million in funding and the acquisition of The Auctus Group, the leading U.S. biller for plastic surgeons and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results